Skip to search formSkip to main contentSkip to account menu

Remission Induction Therapy

Initial treatment with anticancer drugs to decrease the signs or symptoms of cancer or make them disappear.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Evaluation of Hepatocyte Growth Factor in Iraqi Patients with Acute Myeloid Leukemia: Its Correlation with Clinical Parameters and Response to Induction Therapy
BACKGROUND: Hepatocyte growth factor (HGF) is a proangiogenic factor that exerts different effects over stem cell survival growth… 
2014
2014
[Effect of Huangqi injection on short-term prognosis in children with acute lymphoblastic leukemia].
OBJECTIVE To investigate the effect of Huangqi injection on the short-term prognosis in childhood with acute lymphoblastic… 
2011
2011
Increases in body mass index during infliximab therapy in patients with Crohn's disease: an open label prospective study.
2011
2011
High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
We describe MR-CHOP therapy, a novel treatment regimen consisting of high-dose methotrexate and R-CHOP that provides systemic… 
2011
2011
Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience.
6593 Background: Decitabine is a cytosine nucleoside analog that is FDA-approved for previously untreated and treated patients… 
2008
2008
Low expression of APAF-1XL in acute myeloid leukemia may be associated with the failure of remission induction therapy.
Apoptotic protease activating factor 1 (APAF-1) has a critical role in the regulation of apoptosis. In the present study, the… 
2004
2004
Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse
We evaluated the clinical response to low-dose etoposide in relapsed acute lymphoblastic leukemia (ALL). Of the 45 patients with… 
2000
2000
Selection of optimal remission consolidation therapy for individual patients with acute myelogenous leukemia
1997
1997
Haematopoietic cytokines in the biology and treatment of acute myeloid leukaemia.
In acute myeloid leukaemia (AML), age has a definite effect on the biology of the disease and also determines the outcome of… 
1993
1993
Hemolytic uremic syndrome developing during remission of acute myelomonocytic leukemia
A 47‐year‐old woman was diagnosed with acute myelomonocytic leukemia (AMMoL) and was treated with combination chemotherapy. After… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)